CNSP   $2.21  -4.74% Market Open

CNS Pharmaceuticals, Inc.
Total Cash 1.49M
totalCashPerShare 0.046
EBITDA -15.98M
Total Debt 123.25K
quickRatio 0.221
currentRatio 0.317
Total Revenue
debtToEquity
Revenue/Share
ROA -2.24
ROE
grossProfits
freeCashflow -5.19M
operatingCashflow -10.76M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.19M
forwardPE -0.2820513
floatShares 31.43M
sharesOutstanding 40.75M
sharesShort 1.11M
sharesShortPriorMonth 364.58K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.98%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -2.975
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -15.97M
trailingEps -367.38%
forwardEps -0.39%
enterpriseToEbitda -0.14
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.1 4Q 2022
institutionsCount 11
lastUpdated Nov. 7, 2024, 3:05 a.m.